Cognitive Deficits Recruiting Phase 2 Trials for Bazedoxifene (DB06401)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04103476Advancing Postmenopausal Preventive TherapyTreatment